Ozanimod trials for Multiple sclerosis

All Ozanimod trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying Ozanimod for Multiple sclerosis

• Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
  NCT06529406 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
  NCT07732907 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
  NCT06408259 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 33 locations

Common questions

How many trials study Ozanimod for Multiple sclerosis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.